Zeke Capital Advisors’s Bio-Techne TECH Stock Holding History

Zeke Capital Advisors’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-52,000	Closed	-$1.96M	–	695
2018 Q1	$1.96M	Sell	52,000 -1,060	-2%	-$37.5K	0.18%	101
2017 Q4	$1.72M	Buy	53,060 +13,580	+34%	+$431K	0.18%	97
2017 Q3	$1.19M	Buy	39,480 +21,200	+116%	+$629K	0.16%	101
2017 Q2	$537K	Buy	18,280 +4,980	+37%	+$136K	0.1%	123
2017 Q1	$338K	Buy	+13,300	New	+$343K	0.07%	168

Other funds holding TECH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Zeke Capital Advisors's TECH Position: Q2 2018 in Review

Zeke Capital Advisors sold out of Bio-Techne (TECH) in Q2 2018, closing a stake of 52,000 shares — an estimated $1.96M sold.

Zeke Capital Advisors first reported a position in TECH in Q1 2017 and held it in 5 quarters. The position peaked at $1.96M in Q1 2018. 341 funds tracked by Wall St. Rank hold TECH as of Q2 2018.

Zeke Capital Advisors reported no remaining Bio-Techne position as of Q2 2018 after selling out during the quarter.
Zeke Capital Advisors sold 52,000 Bio-Techne shares in Q2 2018, an estimated $1.96M.
Zeke Capital Advisors first reported a position in Bio-Techne in Q1 2017 and held it in 5 quarters.
Zeke Capital Advisors's Bio-Techne position peaked at $1.96M in Q1 2018.
341 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2018.

Based on Zeke Capital Advisors's 13F filing for Q2 2018, filed 24 Jul 2018.